Key result
Gut microbiota dysbiosis is linked to metabolic dysfunction and atherosclerotic cardiovascular disease.
These days, the gut microbiota is universally recognized as an active organ that can modulate the overall host metabolism by promoting multiple functions, from digestion to the systemic maintenance of overall host physiology. Dysbiosis, the alteration of the complex ecologic system of gut microbes, is associated with and causally responsible for multiple types of pathologies. Among the latters, metabolic diseases such as type 2 diabetes and obesity are each distinguishable by a unique gut microbiota profile. Interestingly, the specific microbiota typically found in the blood of diabetic patients also has been observed at the level of atherosclerotic plaque. Here, we report evidence from the literature, as well as a few controversial reports, regarding the putative role of gut microbiota dysbiosis-induced cardiovascular diseases, such as atherosclerosis, which are common comorbidities of metabolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Sérino et al. (2014) conducted a review in Cardiovascular diseases, atherosclerosis, and metabolic diseases (type 2 diabetes and obesity). Gut microbiota dysbiosis was evaluated on Cardiovascular diseases, such as atherosclerosis. Gut microbiota dysbiosis is associated with metabolic dysfunction and cardiovascular diseases such as atherosclerosis, with diabetic blood microbiota profiles also found in atherosclerotic plaques.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: